Xvivo Perfusion AB (publ) ( XVIPF) - Key Metrics
XVIPF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $7.18 | $1 | $2.76 | ? |
| 2025Q3 | $6 | $0.14 | $0.65 | ? |
| 2025Q2 | $5.66 | $0.05 | $0.28 | $0.28 |
XVIPF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 46.43 |
| 2025Q3 | ? | 314.27 |
| 2025Q2 | ? | 1415.77 |
XVIPF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | 0.81% | ? |
| 2025Q4 | 1.45% | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | 0.10% | ? |
XVIPF
Price: $30.95
52 week price:
Earnings Per Share: 0.29 USD
P/E Ratio: 89.90
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 771.7 million